Literature DB >> 9730247

Structure-cytotoxic activity relationship for the toad poison bufadienolides.

Y Kamano1, A Kotake, H Hashima, M Inoue, H Morita, K Takeya, H Itokawa, N Nandachi, T Segawa, A Yukita, K Saitou, M Katsuyama, G R Pettit.   

Abstract

The toad poison bufadienolides including natural and derivatized compounds were tested for their cytotoxic effects on primary liver carcinoma cells PLC/PRF/5 and their structure-cytotoxic activity relationships were studied. For this study, a ligand-binding model was developed by using a pharmacophore mapping program, Distance Comparisons (DISCO). The structural features that are common to the 3D structures of active bufadienolides were identified to provide approach to a 3D QSAR method by using Comparative Molecular Field Analysis (CoMFA) study and to correlate the steric and electrostatic fields of the molecules to their activities. A valuable model which enables prediction of their activities was obtained from the CoMFA analysis, which may be employed for the drug designs of new bufadienolide analogues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730247     DOI: 10.1016/s0968-0896(98)00067-4

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  18 in total

Review 1.  Angel of human health: current research updates in toad medicine.

Authors:  Qian Yang; Xuanxuan Zhou; Meng Zhang; Linlin Bi; Shan Miao; Wei Cao; Yanhua Xie; Jiyuan Sun; Haifeng Tang; Ying Li; Qing Miao; Siwang Wang
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

2.  Antiproliferative Homoisoflavonoids and Bufatrienolides from Urginea depressa.

Authors:  Yumin Dai; Liva Harinantenaina; Peggy J Brodie; Michael Goetz; Yongchun Shen; Karen TenDyke; David G I Kingston
Journal:  J Nat Prod       Date:  2013-05-09       Impact factor: 4.050

3.  A structural view on the functional importance of the sugar moiety and steroid hydroxyls of cardiotonic steroids in binding to Na,K-ATPase.

Authors:  Flemming Cornelius; Ryuta Kanai; Chikashi Toyoshima
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

4.  Specific 12 beta-hydroxylation of cinobufagin by filamentous fungi.

Authors:  Min Ye; Guiqin Qu; Hongzhu Guo; Dean Guo
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

5.  Synthesis of medicinally relevant terpenes: reducing the cost and time of drug discovery.

Authors:  Daniel J Jansen; Ryan A Shenvi
Journal:  Future Med Chem       Date:  2014-06       Impact factor: 3.808

6.  Delisheng, a Chinese medicinal compound, exerts anti-proliferative and pro-apoptotic effects on HepG2 cells through extrinsic and intrinsic pathways.

Authors:  Chuang-xin Lu; Ke-jun Nan; Yan-li Nie; Ya-nan Hai; Min Jiao
Journal:  Mol Biol Rep       Date:  2009-12-11       Impact factor: 2.316

7.  New Insights Into Dietary Toxin Metabolism: Diversity in the Ability of the Natricine Snake Rhabdophis tigrinus to Convert Toad-Derived Bufadienolides.

Authors:  Takato Inoue; Ryu Nakata; Alan H Savitzky; Naoko Yoshinaga; Akira Mori; Naoki Mori
Journal:  J Chem Ecol       Date:  2021-07-14       Impact factor: 2.626

8.  The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells.

Authors:  Chun Li; Saeed M Hashimi; Siyu Cao; Albert S Mellick; Wei Duan; David Good; Ming Q Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

9.  Digitoxin and its analogs as novel cancer therapeutics.

Authors:  Hosam A Elbaz; Todd A Stueckle; William Tse; Yon Rojanasakul; Cerasela Zoica Dinu
Journal:  Exp Hematol Oncol       Date:  2012-04-05

10.  Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway.

Authors:  Ning Tang; Lei Shi; Zhenlong Yu; Peipei Dong; Chao Wang; Xiaokui Huo; Baojing Zhang; Shanshan Huang; Sa Deng; Kexin Liu; Tonghui Ma; Xiaobo Wang; Lijun Wu; Xiao-Chi Ma
Journal:  Oncotarget       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.